RNAi screens in mice identify physiological regulators of oncogenic growth

Beronja, Slobodan;Janki, Peter;Heller, Evan;Lien, Wen-Hui;Fuchs, Elaine;et.al.
(2013) Nature — Vol. 501, n° 7466, p. 185-190 (2013)

Files

2013-Nature.pdf
  • Closed Access
  • Adobe PDF
  • 1.3 MB

Details

Authors
  • Beronja, Slobodan
    Author
  • Janki, Peter
    Author
  • Heller, Evan
    Author
  • Lien, Wen-Huiorcid-logoUCLouvain
    Author
  • Fuchs, Elaine
    Author
Show more
Abstract
Tissue growth is the multifaceted outcome of a cell's intrinsic capabilities and its interactions with the surrounding environment. Decoding these complexities is essential for understanding human development and tumorigenesis. Here we tackle this problem by carrying out the first genome-wide RNA-interference-mediated screens in mice. Focusing on skin development and oncogenic (Hras(G12V)-induced) hyperplasia, our screens uncover previously unknown as well as anticipated regulators of embryonic epidermal growth. Among the top oncogenic screen hits are Mllt6 and the Wnt effector β-catenin, which maintain Hras(G12V)-dependent hyperproliferation. We also expose β-catenin as an unanticipated antagonist of normal epidermal growth, functioning through Wnt-independent intercellular adhesion. Finally, we validate functional significance in mouse and human cancers, thereby establishing the feasibility of in vivo mammalian genome-wide investigations to dissect tissue development and tumorigenesis. By documenting some oncogenic growth regulators, we pave the way for future investigations of other hits and raise promise for unearthing new targets for cancer therapies.
Affiliations

Citations

Beronja, S., Janki, P., Heller, E., Lien, W.-H., Keyes, B. E., Oshimori, N., & Fuchs, E. (2013). RNAi screens in mice identify physiological regulators of oncogenic growth. Nature, 501(7466), 185-190. https://doi.org/10.1038/nature12464 (Original work published 2013)